|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
180.32/-0.41
|
企業價值
15.29M
|
資產負債 |
每股賬面淨值
-1.40
|
現金流量 |
現金流量率
--
|
損益表 |
收益
32.20M
|
每股收益
9.94
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
![](../images/dot.bmp)
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment. |